Brief: Bavarian Nordic Says 750,000 Doses Of MVA-BN Vaccine To Be Delivered In 2026
Nov 1 (Reuters) - Bavarian Nordic A/S BAVA.CO: BAVARIAN NORDIC PROVIDES CLARIFICATION ON THE HERA FRAMEWORK AGREEMENT AND THE PUBLIC PREPAREDNESS BUSINESS BAVARIAN NORDIC - 750,000 DOSES OF MVA-BN VACCINE TO BE DELIVERED IN 2026 BAVARIAN NORDIC: AWARD OF HERA AGREEMENT DOES NOT AFFECT 2025 GUIDANCE. Source text: ID:nGNE7NTwsg Further company coverage: BAVA.CO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bavarian Nordic A/S
See all newsBrief: Bavarian Nordic Gets Smallpox/Mpox Vaccine Supply Contract
Brief: Bavarian Nordic Secures Additional Government Contract For The Supply Of Smallpox/Mpox Vaccine
Brief: Bavarian Nordic Launches Final Tranche Of Buy-Back Program
Bavarian Nordic falls as high costs, lower vaccine sales hit Q1 results
Bavarian Nordic Q1 revenue falls as Public Preparedness unit sales decline